Introdução: A preparação intestinal para colonoscopia e/ou cirurgia coloretal pode induzir alterações hidro-eletrolíticas. O risco destas alterações parece estar relacionado com o tipo de preparação intestinal, idade e comorbilidades dos doentes. Caso Clínico: Os autores apresentam dois casos de hiponatrémia sintomática (sinais neurológicos focais e coma) após preparação intestinal com picossulfato de sódio/citrato de magnésio para colonoscopia. Em ambos os casos, verificou-se resolução completa e rápida do quadro clínico depois da correção da hiponatrémia com solução intravenosa de NaCl a 3%. Discussão: Os distúrbios eletrolíticos são mais frequentes nas preparações à base de fosfato de sódio e picossulfato de sódio/ citrato de magnésio, nos doentes com mais de 65 anos ou medicados com diuréticos tiazídicos, inibidores da enzima de conversão da angiotensina, beta-bloqueantes e antidepressivos e em doentes gastrectomizados. Nestes doentes devemos preferir preparações intestinais à base de macrogol (polyethylene glycol). Conclusão: Em doentes de risco (idade superior a 65 anos, medicados com diuréticos tiazídicos, IECAs, beta-bloqueantes e antidepressivos, e antecedentes de gastrectomia) recomendamos soluções à base de macrogol. Palavras-chave: Catárticos/efeitos adversos; Colonoscopia; Hiponatrémia ABSTRACT Introduction: Bowel preparation for colonoscopy and/or colorectal surgery can cause electrolyte imbalances. The risk of electrolyte imbalances seems to be related to the type of bowel cleansing solution, age of patients and comorbidities. Case Report: We report two cases of symptomatic hyponatremia (focal neurological signs and coma) after bowel preparation with sodium picosulfate/magnesium citrate for colonoscopy. In both cases, symptoms related to hyponatremia rapidly disappeared after sodium level correction with intravenous administration of hypertonic saline (3% NaCl). Discussion: Electrolyte imbalances are more common with sodium phosphate-based solutions (NaP) and sodium picosulfate/ magnesium citrate, in patients older than 65, in patients treated with thiazide diuretics, angiotensin-converting-enzyme inhibitor, betablockers or antidepressants and in gastrectomized patients. These patients should use macrogol-based solutions (polyethylene glycol).
INTRODUCTION
Bowel preparation for colonoscopy or colorectal surgery can cause electrolyte imbalances like hyponatremia which may lead to serious consequences such as seizures, loss of consciousness, neurological symptoms and eventually coma. 1 The risk of these electrolyte imbalances seems to be related to the type of bowel cleansing solution, age of the patient and comorbidities. 2 The authors report two cases of symptomatic hyponatremia after bowel preparation for colonoscopy.
CASE REPORT
In both cases the bowel preparation for total colonoscopy (for colorectal cancer screening) was done with sodium picosulfate/magnesium citrate (MC-SP).
The first case refers to a 64-year-old female with previous total gastrectomy and depression, taking trazodone and diazepam. She was admitted in our Emergency department due to sudden coma. She presented with a Glasgow coma scale of 5/15. Blood tests showed severe hyponatremia (111 mmol/L; reference: 136 -145 mmol/L), hypokalemia (3.3 mEq/L; reference: 3.5 -5.0 mEql/L) and decreased serum osmolality (240 mOsm/kg; reference: 289 -308 mOsm/kg).
The second case refers to a 69-year-old female with hypertension and dyslipidemia treated with losartan, atenolol and atorvastatin, who was brought to our Emergency department due to sudden dysarthria and paresthesias of her upper limbs. Blood tests revealed moderate hyponatremia (128 mmol/L) and decreased serum osmolality (248 mOsm/ kg).
In both cases, there was no history of seizures or alcohol consumption, electrocardiogram was normal and brain computerized tomography and magnetic resonance imaging showed no signs of bleeding or other acute brain injuries.
Patients were considered to have neurological symptoms related to bowel preparation-induced severe acute hyponatremia. Thus, they were treated with slow intravenous infusion of hypertonic saline. Complete neurological recovery and normalization of serum sodium levels occurred in 48 hours in the first case and in 24 hours in the second case.
DISCUSSION
Bowel cleansing is essential to undergo safe and efficient colonoscopy or colorectal surgery. 3 Although usually safe it may be associated with severe complications. 2, 4 The ideal bowel preparation should be easy to drink while achieving excellent bowel cleansing and minimizing adverse impact over the gastrointestinal tract mucosa and electrolyte balance in order to increase the patient's adherence and safety. 5 The most common solutions for colonoscopy preparation include polyethylene glycol (PEG), sodium phosphate (NaP) and MC-SP complex. 2 PEG is an inert polymer of ethyleneoxide, formulated as a nonabsorbable solution designed to pass through the bowel without net absorption nor secretion. Preparations containing PEG do not cause histologic damage in the gastrointestinal tract mucosa. Thus, PEG is considered to be safe for colonic cleansing and complications-free. It is recommended to patients with pre-existing electrolyte imbalances and in patients who cannot tolerate a significant sodium load, namely those with renal failure, congestive heart failure or advanced liver disease with ascites. 2 NaP solutions promote an osmotic influx of fluid from the intravascular compartment to the bowel lumen. Therefore, NaP inevitably carries a possibility of inducing water and electrolyte abnormalities.
6. Nevertheless, it is a good colon cleanser and usually easier to ingest. 7 MC-SP complex acts locally in the colon as a combination of a stimulant laxative to increase frequency and strength of peristaltsis (sodium picosulfate component) and as an osmotic laxative to retain fluid in the colon (magnesium citrate component). 2 Compared with PEG and NaP solutions, it has similar bowel cleaning efficacy but the patient's compliance has been reported to be better than with PEG and NaP. 8 MC-SP complex and NaP have been associated with numerous electrolyte imbalances 1 as well as colonic mucosa inflammation. 2 Electrolyte imbalances are well-recognized complications of bowel preparations and include hyponatremia, hypomagnesemia, hypocalcemia and hypophosphatemia. Whilst hyponatremia is the most frequent one, being reported in up to 7.5% -8.8% patients, it rarely achieves clinical significance. 4, 9 Hyponatremia is defined as a serum sodium level less than 135 mEq/L. Symptoms do not normally occur unless the serum so dium level is lower than 120 mEq/L. However, symptoms might occur at a level above that when the rate of decrease of the serum sodium level is very abrupt. The symptoms range from milder ones, such as loss of appetite, nausea, and vomiting, to more severe ones, such as seizure, lethargy, coma, and even death. If the patient presents with severe neurological symptoms or a serum sodium concentra tion less than 110 mEq/L, urgent treatment is required. 5 Bowel preparation-induced coma is uncommon and there are only four cases reported in the literature. The age of these patients ranged from 64 to 80 years, one patient was taking thiazide diuretics and beta blockers, another patient had a previous history of gastrectomy, two patients used NaP solutions and two other patients used MC-SP complex. 5, 6, 9 Because of the osmotic activity of the chemical contents of the NaP and MC-SP complex, these solutions induce water and electrolyte abnormalities. 10 For this reason, elderly individuals and patients with impaired renal function, liver cirrhosis or congestive heart failure are more prone to these events. 6 Studies that investigated the risk of hyponatremia in elderly patients taking PEG and MC-SP, showed that the incidence of hyponatremia was higher in patients taking MC-SP, even though there were no significant differences in terms of neurological symptoms or length of hospital stay. 11 In order to prevent hyponatremia, patients should be instructed to take MC-SP with a generous amount of water. In addition, care should be taken when using MC-SP complex in patients with impaired renal function, heart failure, inflammatory bowel disease 12 and patients taking drugs for hypertension and depression. 13 Gastrectomy is also considered a risk factor for hyponatremia related to bowel preparation. The rapid emptying of bowel preparation solutions into the small intestine with the addition of accelerated bowel movements may result in an exaggerated intravascular volume contraction and hence in acute hypovolemic hyponatremia. 6 Furthermore, in states of hypovolemia there is a stimulation of water retention through arginine vasopressin (AVP) stimulation of aquaporin (AQP) expression in the renal principal cell, worsening hyponatremia (dilution).
14 Until now, there is no evidence that 'split-dose' regimens avoid or decrease electrolyte imbalances; the advantage of these regimens is the better tolerability with equal effectiveness when compared to standard regimes. 15 Bowel preparation-induced hyponatremia should be treated with slow intravenous infusion of hypertonic saline aiming to increase sodium level at a rate of 0.5 mmol/L/h, not exceeding 12 mmol/L in the first 24 hours nor 18 mmol/L in the first 48 hours to avoid osmotic demyelination and brain edema. Usually, it takes 48h -72h for full clinical and sodium balance recovery. 16 Our report calls the attention to the importance of the patient´s medical history when choosing a bowel preparation solution. Moreover, in patients presenting with neurological symptoms while taking these solutions, we should evaluate serum electrolytes and start treatment immediately.
